Aromatase inhibitors reverse tamoxifen induced endometrial ultrasonographic changes in postmenopausal breast cancer patients

被引：0
|
作者：
O. Markovitch
R. Tepper
A. Fishman
R. Aviram
I. Cohen
机构：
[1] Meir Medical Center,Department of Obstetrics and Gynecology
[2] Sackler Faculty of Medicine,Gynecological Ultrasound Unit
[3] Tel Aviv University,undefined
[4] Meir Medical Center,undefined
来源：
Breast Cancer Research and Treatment | 2007年 / 101卷
关键词：
Endometrial thickness; Aromatase inhibitors; Tamoxifen; Ultrasound;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：185 / 190
页数：5
相关论文
共 50 条
  • [1] Aromatase inhibitors reverse tamoxifen induced endometrial ultrasonographic changes in postmenopausal breast cancer patients
    Markovitch, O.
    Tepper, R.
    Fishman, A.
    Aviram, R.
    Cohen, I.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 101 (02) : 185 - 190
  • [2] Aromatase inhibitors and postmenopausal breast cancer patients with tamoxifen-induced endometrial pathology
    Morales, Leilani
    Paridaens, Robert
    Timmerman, Dirk
    Neven, Patrick
    [J]. CLINICAL CANCER RESEARCH, 2006, 12 (18) : 5603 - 5603
  • [3] Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients
    Morales, L
    Timmerman, D
    Neven, P
    Konstantinovic, ML
    Carbonez, A
    Van Huffel, S
    Ameye, L
    Weltens, C
    Christiaens, MR
    Vergote, I
    Paridaens, R
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (01) : 70 - 74
  • [4] Endometrial cancer risk in postmenopausal breast cancer patients treated with tamoxifen or aromatase inhibitors
    Sestak, Ivana
    Cuzick, Jack
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2016, 11 (05) : 425 - 432
  • [5] Ultrasonographic measurement of endometrial changes following discontinuation of tamoxifen treatment in postmenopausal breast cancer patients
    Cohen, I
    Beyth, Y
    Azaria, R
    Flex, D
    Figer, A
    Tepper, R
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2000, 107 (09): : 1083 - 1087
  • [6] Ultrasonographic evaluation of endometrial disease in postmenopausal patients with breast cancer and tamoxifen treatment
    Cohen, I
    Tepper, R
    Beyth, Y
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 180 (01) : 252 - 252
  • [7] Changes in endometrial thickness after conversion from tamoxifen to aromatase inhibitor in postmenopausal breast cancer patients
    Hwang, Kyuri
    Hwang, Ki Tae
    Kim, Yong Jin
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2017, 24 (12): : 1452 - 1452
  • [8] Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivors
    Chlebowski, Rowan T.
    Schottinger, Joanne E.
    Shi, Jiaxiao
    Chung, Joanie
    Haque, Reina
    [J]. CANCER, 2015, 121 (13) : 2147 - 2155
  • [9] ENDOMETRIAL CHANGES IN POSTMENOPAUSAL BREAST-CANCER PATIENTS RECEIVING TAMOXIFEN
    LAHTI, E
    BLANCO, G
    KAUPPILA, A
    APAJASARKKINEN, M
    TASKINEN, PJ
    LAATIKAINEN, T
    [J]. OBSTETRICS AND GYNECOLOGY, 1993, 81 (05): : 660 - 664
  • [10] Aromatase inhibitors reverse tamoxifen-induced uterine changes?
    [J]. Reactions Weekly, 2005, 1034 (1) : 5 - 5
12345